Literature DB >> 13852856

Survival in an afibrinogenaemic subject of fibrinogen prepared from "time-expired" blood.

G I INGRAM, J L PINNIGER, L VALLET.   

Abstract

Entities:  

Keywords:  AFIBRINOGENEMIA/therapy; BLOOD TRANSFUSION

Mesh：

Substances：

Year:  1960        PMID： 13852856     DOI： 10.1016/s0140-6736(60)90055-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  [CONGENITAL AFIBRINOGENEMIA: A REPORT OF 4 CASES].

Authors:  J M DELAGE; A BARRY
Journal:  Can Med Assoc J       Date:  1964-05-30       Impact factor: 8.262

2.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors:  A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

3.  [Diagnostic and therapeutic problems in congenital afibrinogenemia].

Authors:  R Egbring; K Andrassy; H Egli; J Meyer-Lindenberg
Journal:  Blut       Date:  1971-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.